These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34392792)

  • 1. Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in
    Han X; Wang Y; Zhang P; Zhu M; Li L; Mao X; Sha X; Li L
    Pharm Biol; 2021 Dec; 59(1):1077-1087. PubMed ID: 34392792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation improves metabolism and gut microbiome composition in db/db mice.
    Zhang PP; Li LL; Han X; Li QW; Zhang XH; Liu JJ; Wang Y
    Acta Pharmacol Sin; 2020 May; 41(5):678-685. PubMed ID: 31937933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice.
    Wang Y; Dilidaxi D; Wu Y; Sailike J; Sun X; Nabi XH
    Biomed Pharmacother; 2020 May; 125():109914. PubMed ID: 32035395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uygur type 2 diabetes patient fecal microbiota transplantation disrupts blood glucose and bile acid levels by changing the ability of the intestinal flora to metabolize bile acids in C57BL/6 mice.
    Wang C; Wang Y; Yang H; Tian Z; Zhu M; Sha X; Ran J; Li L
    BMC Endocr Disord; 2022 Sep; 22(1):236. PubMed ID: 36151544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db/db mice.
    Chen L; Guo L; Feng S; Wang C; Cui Z; Wang S; Lu Q; Chang H; Hang B; Snijders AM; Mao JH; Lu Y; Ding D
    BMJ Open Diabetes Res Care; 2023 May; 11(3):. PubMed ID: 37253485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.
    Yi ZY; Chen L; Wang Y; He D; Zhao D; Zhang SH; Yu R; Huang JH
    Acta Diabetol; 2022 Oct; 59(10):1295-1308. PubMed ID: 35857109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway.
    Xia T; He W; Luo Z; Wang K; Tan X
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132256. PubMed ID: 38729481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary fiber of Tartary buckwheat bran modified by steam explosion alleviates hyperglycemia and modulates gut microbiota in db/db mice.
    He X; Li W; Chen Y; Lei L; Li F; Zhao J; Zeng K; Ming J
    Food Res Int; 2022 Jul; 157():111386. PubMed ID: 35761642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
    Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
    Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota-derived acetate attenuates lung injury induced by influenza infection via protecting airway tight junctions.
    Hu L; Sun L; Yang C; Zhang DW; Wei YY; Yang MM; Wu HM; Fei GH
    J Transl Med; 2024 Jun; 22(1):570. PubMed ID: 38879538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short chain fatty acids contribute to gut microbiota-induced promotion of colonic melatonin receptor expression.
    Wang B; Zhang L; Zhu SW; Zhang JD; Duan LP
    J Biol Regul Homeost Agents; 2019; 33(3):763-771. PubMed ID: 31204469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
    Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
    Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of birth mode of delivery with infant faecal microbiota, potential pathobionts, and short chain fatty acids: a longitudinal study over the first year of life.
    Mueller NT; Differding MK; Østbye T; Hoyo C; Benjamin-Neelon SE
    BJOG; 2021 Jul; 128(8):1293-1303. PubMed ID: 33338292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon.
    Christiansen CB; Gabe MBN; Svendsen B; Dragsted LO; Rosenkilde MM; Holst JJ
    Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G53-G65. PubMed ID: 29494208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids.
    Ducastel S; Touche V; Trabelsi MS; Boulinguiez A; Butruille L; Nawrot M; Peschard S; Chávez-Talavera O; Dorchies E; Vallez E; Annicotte JS; Lancel S; Briand O; Bantubungi K; Caron S; Bindels LB; Delzenne NM; Tailleux A; Staels B; Lestavel S
    Sci Rep; 2020 Jan; 10(1):174. PubMed ID: 31932631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats.
    An Y; Dai H; Duan Y; Cheng L; Shi L; He C; Wang C; Lv Y; Li H; Zhang H; Huang Y; Fu W; Sun W; Zhao B
    Chin Med; 2023 May; 18(1):49. PubMed ID: 37147692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eucommia bark/leaf extract improves HFD-induced lipid metabolism disorders via targeting gut microbiota to activate the Fiaf-LPL gut-liver axis and SCFAs-GPR43 gut-fat axis.
    Wang Z; Sun Y; Han Y; Chen X; Gong P; Zhai P; Yao W; Ba Q; Wang H
    Phytomedicine; 2023 Feb; 110():154652. PubMed ID: 36638713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
    de Groot P; Scheithauer T; Bakker GJ; Prodan A; Levin E; Khan MT; Herrema H; Ackermans M; Serlie MJM; de Brauw M; Levels JHM; Sales A; Gerdes VE; Ståhlman M; Schimmel AWM; Dallinga-Thie G; Bergman JJ; Holleman F; Hoekstra JBL; Groen A; Bäckhed F; Nieuwdorp M
    Gut; 2020 Mar; 69(3):502-512. PubMed ID: 31147381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in gut microbiota, metabolite SCFAs, and GPR43 expression in obese diabetic mice after sleeve gastrectomy.
    Guo Y; Liu C; Zhao X; Zhang X; Wu Q; Wang Z; Lu J
    J Appl Microbiol; 2022 Aug; 133(2):555-568. PubMed ID: 35437874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.